The Need

Tumor resistance to chemotherapy is one of the major obstacles to successful cancer care.  In the United States alone, about 500,000 cancer deaths each year can be attributed to chemotherapy resistance.  Clearly a new approach is needed to help patients with potentially drug-resistant cancer. Read more >

Our Focus

We are focused on the development of non-toxic drugs that enhance the efficacy of chemotherapy in patients with drug-resistant cancer.  Second-line ovarian cancer and Non-Hodgkin’s lymphoma are our initial areas of focus.  We are also studying triple-negative breast, prostate, pancreatic and other cancers.   Read More >